Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer
Release date: 09-05-2024
Expiration date: 08-05-2025
Opening & Keynote Speech: Second-line and salvage treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)
Philippe Barthélémy, MD, PhD
Institute of Cancer in Strasbourg (ICANS)
Strasbourg, France
-
Opening & Keynote Speech: Second-line and salvage treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)
Philippe Barthélémy, MD, PhD
-
Case 1: Second-line and salvage treatment options after maintenance immunotherapy & Case 2: Second-line and salvage treatment options after platinum-based chemotherapy
Kate Smith, MBBS, MRCP, MD, PhD
-
Panel Discussion & Pearls for Practice
Aristotelis Bamias, MD, PhD